Takara Bio Inc. (TKBIF) Comparison with companies in other sectors?

Takara Bio Inc. has a share price of 120.42M. You can analyze Takara Bio Inc. (TKBIF) competitors across different market sectors through stock heatmaps.

What are TKBIF's NET and operating margins?

Takara Bio Inc. (TKBIF) operating margin is around N/A, and net profit margin is approximately N/A as of the latest reports.

In what way does TKBIF's earnings per share (EPS) trend reflect its financial momentum?

Takara Bio Inc. (TKBIF) EPS is 1.24 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Takara Bio Inc. is 18.71, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Takara Bio Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Takara Bio Inc. like P/E which is N/A, P/B which is N/A, and PEG which is N/A. Compare them with sector averages to evaluate if the stock is priced fairly.

Takara Bio Inc.

TKBIF•PNK

Healthcare

Biotechnology

$23.20

$0.00(0.00%)

Takara Bio Inc. (TKBIF) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$1.24

P/E Ratio

18.71

ROE

Net Margin

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$2.79B

Shares OutstandingTotal number of shares issued

$120.42M

Book Value/ShareNet worth per share

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$1.24

Net MarginNet income as percentage of revenue

Operating MarginOperating income as percentage of revenue

ROEReturn on shareholders' equity

ROAReturn on total assets

ROCEReturn on capital employed

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

FCF YieldFree cash flow as percentage of market cap

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for TKBIFFinancial Ratios Analysis details for TKBIF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for TKBIFSector Benchmarking details for TKBIF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Takara Bio Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Takara Bio Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Takara Bio Inc.'s unique business strengths and challenges.

Key Financial Metrics for Takara Bio Inc.

For Takara Bio Inc., essential financial indicators include EPS 1.24, PE 18.71, and ROE -. These key ratios reveal insights into Takara Bio Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Takara Bio Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Takara Bio Inc.

Metrics like Net Margin - and ROA - shed light on how well Takara Bio Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Takara Bio Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Takara Bio Inc.

Using ratios such as P/B Ratio - and PEG Ratio -, investors can assess whether Takara Bio Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Takara Bio Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Takara Bio Inc.

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow -, provide a snapshot of Takara Bio Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Takara Bio Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Takara Bio Inc.

Investing in Takara Bio Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Takara Bio Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;